Search

Author/Creator Loewe, R.

1. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE). (15th November 2016)

Authors:
Mrowietz, U.; Szepietowski, J.C.; Loewe, R.; van de Kerkhof, P.; Lamarca, R.; Ocker, W.G.; Tebbs, V.M.; Pau‐Charles, I.
Journal:
British journal of dermatology
Issue:
Volume 176:Number 3(2017)
Page Start:
615
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE). (1st March 2017)

Authors:
Mrowietz, U.; Szepietowski, J.C.; Loewe, R.; van de Kerkhof, P.; Lamarca, R.; Ocker, W.G.; Tebbs, V.M.; Pau‐Charles, I.
Journal:
British journal of dermatology
Issue:
Volume 176:Number 3(2017)
Page Start:
615
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study. (17th October 2019)

Authors:
van de Kerkhof, P.C.M.; Loewe, R.; Mrowietz, U.; Falques, M.; Pau‐Charles, I.; Szepietowski, J.C.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 34:Number 1(2020)
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗